Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol.

Sec. Parasite and Host

Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1681807

RNA and protein immunization with Trypanosoma cruzi Trans-sialidase containing SAPA repeats protects mice against infection and promotes a balanced inflammatory response

Provisionally accepted
Nailma  Silva Aprigio dos SantosNailma Silva Aprigio dos Santos1Carlos Roberto  Almeida-JuniorCarlos Roberto Almeida-Junior1Mayra  Fernanda RicciMayra Fernanda Ricci1Rodrigo  SanchesRodrigo Sanches1Renata  Salgado FernandesRenata Salgado Fernandes1Gabriela  de Assis Burle CaldasGabriela de Assis Burle Caldas1Júlia  Teixeira de CastroJúlia Teixeira de Castro1João  Luís Reis CunhaJoão Luís Reis Cunha2Daniella  Castanheira BartholomeuDaniella Castanheira Bartholomeu1Ana Clara  Martins MeiraAna Clara Martins Meira1Thaiane  Gomes NascimentoThaiane Gomes Nascimento1Natália Fernanda  Melo de OliveiraNatália Fernanda Melo de Oliveira1Ricardo  Tostes GazzinelliRicardo Tostes Gazzinelli1Fabiana  Simão MachadoFabiana Simão Machado1SANTUZA MARIA  RIBEIRO TEIXEIRASANTUZA MARIA RIBEIRO TEIXEIRA1*
  • 1Federal University of Minas Gerais, Belo Horizonte, Brazil
  • 2University of York, York, United Kingdom

The final, formatted version of the article will be published soon.

Proteins with repeat domains are commonly found in protozoan parasites. Trypanosoma cruzi, which causes Chagas disease (CD), possesses a group of surface proteins called trans-sialidases (TS). These proteins are responsible for transferring sialic acid from the host's glycoconjugates to the parasite's mucins. The TS proteins feature a C-terminal immunogenic domain that includes amino acid repeats known as SAPA (Shed Acute Phase Antigen). Shed in the blood of the infected host, TS mediates several biological effects and because of its essential role during infection, it has been tested recurrently as a vaccine candidate against CD. Here, we investigate the effect of immunizing mice with recombinant TS proteins with and without (w/o) SAPA repeats, as well as with a protein containing only the repeat domain. We also immunize mice with RNA formulations encoding TS sequences with and without SAPA. Besides confirming the immunodominance of the SAPA domain, after challenging immunized animals with T. cruzi, we showed that the presence of the repeats did not significantly impact protection and parasite numbers after infection. However, immunization with TS protein or RNA containing the repeat domain resulted in increased production of IL-10 compared to mice immunized with TS without SAPA, and this increased IL-10 production correlates with a significant reduction in the inflammatory infiltrate in heart tissues of infected animals. These results indicate that the immunodominant SAPA domain plays a role in promoting an anti-inflammatory response, which, as a vaccine component, may contribute to induce a desirable, more balanced immune response.

Keywords: Chagas Disease, trans-sialidase, SAPA repeats, RNA, LNP, Vaccine

Received: 07 Aug 2025; Accepted: 25 Sep 2025.

Copyright: © 2025 dos Santos, Almeida-Junior, Ricci, Sanches, Fernandes, Burle Caldas, de Castro, Cunha, Bartholomeu, Meira, Nascimento, de Oliveira, Gazzinelli, Machado and TEIXEIRA. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: SANTUZA MARIA RIBEIRO TEIXEIRA, santuzat@ufmg.br

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.